来自MSN2 天
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales
Shares of Bausch Health Companies Inc. BHC gained 2.36% after the company reported better-than-expected fourth-quarter ...
emjreviews.com4 天
Study Finds No Benefit of Drug Combination in Cirrhosis
Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...